We further examined the proportions of CD4+ T cells, CD8+ T cells, Foxp3+ regulatory T lymphocytes (T-regs), and IFN-γ+ cytotoxic T lymphocytes (CTLs) in the different groups of tumor tissues to determine the effects of miR-200a on anti-tumor immunity in vivo. This evidence concerns the gene FOXP3 and neoplasm.